LY320135 is a Potent and Selective CB1 Receptor Antagonist
Cannabinoids (CBs) implicate in a number of physiological and pathological mechanisms in the central nervous system. The cannabinoid receptor family consists of two GPCRs, cannabinoid receptor 1 (CB1) and cannabinoid…